Authors

• Isolde Van der Massen
• Annemiek Walenkamp (ORCID: https://orcid.org/0000-0003-4958-8960)
• Ivan Borbath (ORCID: https://orcid.org/0000-0001-7598-214X)
• Wouter W. de Herder (ORCID: https://orcid.org/0000-0003-1463-5165)
• Marc Peeters (ORCID: https://orcid.org/0000-0003-4969-2303)
• Christophe M. Deroose (ORCID: https://orcid.org/0000-0002-6080-1577)
• Johannes Hofland (ORCID: https://orcid.org/0000-0003-0679-6209)
• Iris Verhaegen (ORCID: https://orcid.org/0000-0002-7496-7439)
• Philippe Beutels (ORCID: https://orcid.org/0000-0001-5034-3595)
• Timon Vandamme (ORCID: https://orcid.org/0000-0003-3701-5305)
• Suzanne Polinder (ORCID: https://orcid.org/0000-0002-4331-3141)
• Elke Smits (ORCID: https://orcid.org/0000-0002-8129-2193)
• Ella Roelant (ORCID: https://orcid.org/0000-0002-9902-6328)
• Siddharth Chhajlani (ORCID: https://orcid.org/0000-0002-6291-0371)
• Jelka Kuiper
• Wouter Dercksen
• Stella Heemskerk

Institutions

• Cliniques Universitaires Saint-Luc (BE)
• University Medical Center Groningen (NL)
• Radboud University Nijmegen (NL)
• University of Antwerp (BE)
• Antwerp University Hospital (BE)
• Máxima Medisch Centrum (NL)
• Erasmus MC Cancer Institute (NL)
• KU Leuven (BE)

Publication Details

Journal

BMJ Open

Published

2025-07-01

DOI

https://doi.org/10.1136/bmjopen-2025-099996

Citations

1

Primary Topic

Neuroendocrine Tumor Research Advances

Type

article

Field-Weighted Citation Impact

1.35